The Global Radiotherapy, Radiopharmaceuticals & Nuclear Medicine market is estimated at over $XX billion in 2018, with a projected CAGR of XX.X% during the forecast period.
TABLE OF CONTENTS Chapter 1 Introduction 1.1 Executive Summary 1.2 Market Definition 1.3 Market Scope Chapter 2 Research Methodology 2.1 Primary Research 2.2 Research Methodology 2.3 Assumptions & Exclusions 2.4 Secondary Data Sources Chapter 3 Market Overview 3.1 Report Segmentation & Scope 3.2 Key Market Trends 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunities 3.3 Porter’s Five Forces Analysis 3.4 Market Share Analysis Chapter 4 Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Type: Market Size and Forecast, 2018 – 2026 4.1 Introduction 4.1.1 Market Size and Forecast 4.2 Radiotherapy 4.2.1 Market Size and Forecast 4.3 External Beam Radiation Therapy 4.3.1 Market Size and Forecast 4.4 Internal Radiation Therapy 4.4.1 Market Size and Forecast 4.5 Systematic Radiotherapy 4.5.1 Market Size and Forecast 4.6 Radiopharmaceuticals 4.6.1 Market Size and Forecast 4.7 Diagnostics 4.7.1 Market Size and Forecast 4.8 Therapeutics 4.8.1 Market Size and Forecast Chapter 5 Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Production Type: Market Size and Forecast, 2018 – 2026 5.1 Introduction 5.1.1 Market Size and Forecast 5.2 Particle Accelerators (Cyclotrons) 5.2.1 Market Size and Forecast 5.3 Working of Particle Accelerators 5.3.1 Market Size and Forecast 5.4 Nuclear Reactors 5.4.1 Market Size and Forecast 5.5 Radionuclide Generators 5.5.1 Market Size and Forecast 5.6 Production of Radioisotopes Through Radionuclides 5.6.1 Market Size and Forecast Chapter 6 Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Technology: Market Size and Forecast, 2018 – 2026 6.1 Introduction 6.1.1 Market Size and Forecast 6.2 External Radiotherapy 6.2.1 Market Size and Forecast 6.2.2 Particle Therapy/Proton Beam Therapy 6.2.2.1 Market Size and Forecast 6.2.3 Stereotactic Radiosurgery (SRS) and Fractioned Stereotactic Radiation Therapy 6.2.3.1 Market Size and Forecast 6.2.4 Image-Guided Radiation Therapy (IGRT) 6.2.4.1 Market Size and Forecast 6.2.5 Intensity-Modulated Radiation Therapy (IMRT) 6.2.5.1 Market Size and Forecast 6.2.6 Tomotherapy 6.2.6.1 Market Size and Forecast 6.2.7 Three-Dimensional Conformal Radiation Therapy (3D-CRT) 6.2.7.1 Market Size and Forecast 6.2.8 Volumetric Modulated Arc Therapy (VMAT) 6.2.8.1 Market Size and Forecast 6.3 Internal Radiotherapy 6.3.1 Market Size and Forecast 6.3.2 Pulse-Dose-Rate (PRD) Brachytherapy 6.3.2.1 Market Size and Forecast 6.3.3 Low-Dose-Rate Brachytherapy 6.3.3.1 Market Size and Forecast 6.3.4 High-Dose-Rate (HRD) Brachytherapy 6.3.4.1 Market Size and Forecast 6.4 Systematic Radiotherapy 6.4.1 Market Size and Forecast 6.4.2 Comparison between Alpha and Beta Emitters 6.4.2.1 Market Size and Forecast Chapter 7 Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Application: Market Size and Forecast, 2018 – 2026 7.1 Introduction 7.1.1 Market Size and Forecast 7.2 External Beam Radiation Therapy 7.2.1 Market Size and Forecast 7.2.2 Treatment Planning for External Beam Radiation 7.2.2.1 Market Size and Forecast 7.2.3 Dosing and Treatment with External Beam Radiation 7.2.3.1 Market Size and Forecast 7.2.4 Electron-Emitting High-Energy Linear Accelerators 7.2.4.1 Market Size and Forecast 7.3 Internal Radiation Therapy 7.3.1 Market Size and Forecast 7.4 Systematic Radiation Therapy 7.4.1 Market Size and Forecast Chapter 8 Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Geography: Market Size and Forecast, 2018 – 2026 8.1 Introduction 8.1.1 Market Size and Forecast 8.2 North America 8.2.1 North America Market Size & Forecast, By Country 8.2.2 North America Market Size & Forecast, By Type 8.2.3 North America Market Size & Forecast, By Production Type 8.2.4 North America Market Size & Forecast, By Technology 8.2.5 North America Market Size & Forecast, By Application 8.2.6 The U.S. 8.2.6.1 Market Size and Forecast 8.2.7 Canada 8.2.7.1 Market Size and Forecast 8.2.8 Mexico 8.2.8.1 Market Size and Forecast 8.3 Europe 8.3.1 Europe Market Size and Forecast, By Country 8.3.2 Europe Market Size and Forecast, By Type 8.3.3 Europe Market Size and Forecast, By Production Type 8.3.4 Europe Market Size and Forecast, By Technology 8.3.5 Europe Market Size and Forecast, By Application 8.3.6 UK 8.3.6.1 Market Size and Forecast 8.3.7 Germany 8.3.7.1 Market Size and Forecast 8.3.8 France 8.3.8.1 Market Size and Forecast 8.3.9 Italy 8.3.9.1 Market Size and Forecast 8.3.10 Spain 8.3.10.1 Market Size and Forecast 8.3.11 Rest of Europe 8.3.11.1 Market Size and Forecast 8.4 Asia-Pacific 8.4.1 Asia-Pacific Market Size and Forecast, By Country 8.4.2 Asia-Pacific Market Size and Forecast, By Type 8.4.3 Asia-Pacific Market Size and Forecast, By Production Type 8.4.4 Asia-Pacific Market Size and Forecast, By Technology 8.4.5 Asia-Pacific Market Size and Forecast, By Application 8.4.6 India 8.4.6.1 Market Size and Forecast 8.4.7 China 8.4.7.1 Market Size and Forecast 8.4.8 Australia 8.4.8.1 Market Size and Forecast 8.4.9 Japan 8.4.9.1 Market Size and Forecast 8.4.10 South Korea 8.4.10.1 Market Size and Forecast 8.4.11 Rest of Asia-Pacific 8.4.11.1 Market Size and Forecast 8.5 South America 8.5.1 South America Market Size and Forecast, By Country 8.5.2 South America Market Size and Forecast, By Type 8.5.3 South America Market Size and Forecast, By Production Type 8.5.4 South America Market Size and Forecast, By Technology 8.5.5 South America Market Size and Forecast, By Application 8.5.6 Brazil 8.5.6.1 Market Size and Forecast 8.5.7 Rest of South America 8.5.7.1 Market Size and Forecast 8.6 RoW 8.6.1 RoW Market Size and Forecast, By Country 8.6.2 RoW Market Size and Forecast, By Type 8.6.3 RoW Market Size and Forecast, By Production Type 8.6.4 RoW Market Size and Forecast, By Technology 8.6.5 RoW Market Size and Forecast, By Application 8.6.6 Middle East 8.6.6.1 Market Size and Forecast 8.6.7 Africa 8.6.7.1 Market Size and Forecast Chapter 9 Company Profiles 9.1 Accuray Inc. 9.2 Actinium Pharmaceuticals Inc. 9.3 Alliance Medical Group 9.4 Australian Nuclear Science And Technology Organisation 9.5 Bayer Pharma Ag 9.6 Board Of Radiation And Isotope Technology 9.7 C. R. Bard Inc. (Becton Dickinson) 9.8 Cardinal Health Inc. 9.9 Fujifilm Ri Pharma Co. Ltd. 9.10 GE Healthcare 9.11 Lantheus Medical Imaging Inc. 9.12 National Centre For Nuclear Research Polatom 9.13 National Institute For Radioelements (Ire) 9.14 NTP Radioisotopes Soc Ltd. 9.15 Siemens Healthineers 9.16 Spectrum Pharmaceuticals Inc. 9.17 Varian Medical Systems 9.18 Zevacor Molecular
(US)
